企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：9年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：7948944
手机网站：http://wap.app17.com/c137908/
旗舰版网址：http://www.yajiml.com
技术文章
文献引用产品：小鼠棕榈酸（palmiticacid）Elisa试剂盒
点击次数：943 发布时间：2026/4/7 9:55:33
文章标题：Exploration of the mechanism of Qi-Xian decoction in asthmatic mice using ｍmbedbolomics combined with network pharmacology
作者列表：Yuhua Lin, Yue Wu, Fuqi Ma, Cuiting Shan, Jialu Ma, Wenguan Li, Huayang Pan, Xiayi Miao, Jinjin Liu, Xiongbiao Wang, Zhenhua Ni
影响因子：5
期刊：Frontiers in Molecular Biosciences
发表时间：2023-12-13
DOI:10.3389/fmolb.2023.1263962
文献主题：
Abstract
Introduction: Qi-Xian Decoction (QXD), a traditional Chinese medicine (TCM) ｆormula consisting of eight herbs, has been clinically used to treat asthma. However, the underlying mechanisms have not been completely elucidated. This study aimed to combine ｍmbedbolomics and network pharmacology to reveal the mechanism of action of QXD in asthma treatment.
Methods: An ovalbumin (OVA)-induced asthma mouse model was constructed to evaluate the therapeutic effects of QXD. Serum ｍmbedbolomics and network pharmacology were combined to study the mechanism of anti-asthma action as well as the potential target, and related biological functions were validated.
原创作者：上海雅吉生物科技有限公司
